Literature DB >> 15198666

Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin.

Kristine Baerwald-de la Torre1, Uwe Winzen, Willi Halfter, John L Bixby.   

Abstract

Agrin is a proteoglycan that can inhibit neurite outgrowth from multiple neuronal types when present as a substrate. Agrin's neurite inhibitory activity is confined to the N-terminal segment of the protein (agrin N150), which contains heparan sulfate (HS) and chondroitin sulfate (CS) side chains. We have examined the activities of various purified recombinant agrin fragments and their glycosaminoglycan (GAG) side chains in neurite outgrowth inhibition. Inhibitory activity was tested using dissociated chick ciliary ganglion neurons or dorsal root ganglion explants growing on laminin or N-cadherin. Initial experiments demonstrated that agrin N150 lacking GAG chains inhibited neurite outgrowth. Both halves of N150, each containing HS and/or CS side chains, could also inhibit neurite growth. Experiments using agrin fragments in which the GAG acceptor residues were mutated, or using agrin fragments purified from cells deficient in GAG synthesis, demonstrated that inhibition by the N-terminal portion of N150 requires GAGs, but that inhibition from the C-terminal part of N150 does not. Thus, the core protein or other types of glycosylation are important for inhibition from the more C-terminal region. Our results suggest that there are two distinct mechanisms for neurite outgrowth inhibition by agrin, one that is GAG-dependent and one that is GAG-independent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198666     DOI: 10.1111/j.1471-4159.2004.02454.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  The process-inducing activity of transmembrane agrin requires follistatin-like domains.

Authors:  Elmar Porten; Beate Seliger; Verena A Schneider; Stefan Wöll; Daniela Stangel; Rene Ramseger; Stephan Kröger
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

2.  Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin.

Authors:  Peter G Fuerst; Steven M Rauch; Robert W Burgess
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

3.  Agrin binds BMP2, BMP4 and TGFbeta1.

Authors:  László Bányai; Peter Sonderegger; László Patthy
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

4.  Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth.

Authors:  Naoki Ichikawa; Kazuhisa Iwabuchi; Hidetake Kurihara; Kumiko Ishii; Toshihide Kobayashi; Takako Sasaki; Nobutaka Hattori; Yoshikuni Mizuno; Kentaro Hozumi; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

Review 5.  Molecular mechanisms of scar-sourced axon growth inhibitors.

Authors:  Yosuke Ohtake; Shuxin Li
Journal:  Brain Res       Date:  2014-09-01       Impact factor: 3.252

Review 6.  Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.

Authors:  Renato V Iozzo; Liliana Schaefer
Journal:  Matrix Biol       Date:  2015-02-18       Impact factor: 11.583

7.  Cell adhesion to agrin presented as a nanopatterned substrate is consistent with an interaction with the extracellular matrix and not transmembrane adhesion molecules.

Authors:  Tobias Wolfram; Joachim P Spatz; Robert W Burgess
Journal:  BMC Cell Biol       Date:  2008-12-04       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.